These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1298037)

  • 41. [Therapy of osteoporosis with fluorides and calcitonins].
    Ringe JD
    Internist (Berl); 1991 Feb; 32(2):80-9. PubMed ID: 2032792
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intranasal salmon calcitonin for the prophylaxis of bone mineral loss in steroid-treated chronic obstructive lung diseases ].
    Böhning W; Ringe JD; Welzel D; Bode V
    Arzneimittelforschung; 1990 Sep; 40(9):1000-3. PubMed ID: 2080934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.
    Sileghem A; Geusens P; Dequeker J
    Ann Rheum Dis; 1992 Jun; 51(6):761-4. PubMed ID: 1616360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nasal salmon calcitonin in osteoporosis.
    Overgaard K; Riis BJ
    Calcif Tissue Int; 1994 Aug; 55(2):79-81. PubMed ID: 7953983
    [No Abstract]   [Full Text] [Related]  

  • 47. Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis.
    Gennari C
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():61-5. PubMed ID: 2667872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of nasal calcitonin in the treatment of post-traumatic algodystrophy.
    Bickerstaff DR; Kanis JA
    Br J Rheumatol; 1991 Aug; 30(4):291-4. PubMed ID: 1863827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral calcitonin.
    Maricic MJ
    Curr Osteoporos Rep; 2012 Mar; 10(1):80-5. PubMed ID: 22281725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen and bone metabolism.
    Duursma SA; Raymakers JA; Boereboom FT; Scheven BA
    Obstet Gynecol Surv; 1992 Jan; 47(1):38-44. PubMed ID: 1734333
    [No Abstract]   [Full Text] [Related]  

  • 51. Beta-2 microglobulins in postmenopausal osteoporosis.
    Akinci A; Ozçakar L
    Rheumatol Int; 2002 Aug; 22(4):173-4. PubMed ID: 12418487
    [No Abstract]   [Full Text] [Related]  

  • 52. [The postmenopausal form of osteoporosis].
    Rodionova SS
    Ter Arkh; 1997; 69(10):21-4. PubMed ID: 9471783
    [No Abstract]   [Full Text] [Related]  

  • 53. Effectiveness of salmon calcitonin nasal spray preparation in migraine treatment.
    Micieli G; Cavallini A; Martignoni E; Covelli V; Facchinetti F; Nappi G
    Headache; 1988 Apr; 28(3):196-200. PubMed ID: 3290159
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of calcitonin in the prevention of osteoporosis.
    Avioli LV
    Endocrinol Metab Clin North Am; 1998 Jun; 27(2):411-8. PubMed ID: 9669146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular changes in bone collagen in osteoporosis and osteoarthritis in the elderly.
    Bailey AJ; Knott L
    Exp Gerontol; 1999 Jun; 34(3):337-51. PubMed ID: 10433388
    [No Abstract]   [Full Text] [Related]  

  • 56. Bone patterns in osteoporosis.
    Nordin BE; Young MM; Bentley B; Sykes J
    Calcif Tissue Res; 1968; ():Suppl:56. PubMed ID: 5721078
    [No Abstract]   [Full Text] [Related]  

  • 57. Calcitonin and bone diseases.
    Reginster JY
    Lancet; 1992 Apr; 339(8800):1064-5. PubMed ID: 1349097
    [No Abstract]   [Full Text] [Related]  

  • 58. Postmenopausal osteoporosis: prevention and treatment with calcitonin.
    Prelevic GM; Adashi EY
    Gynecol Endocrinol; 1992 Jun; 6(2):141-7. PubMed ID: 1502932
    [No Abstract]   [Full Text] [Related]  

  • 59. What PROOF proves about calcitonin and clinical trials.
    Cummings SR; Chapurlat RD
    Am J Med; 2000 Sep; 109(4):330-1. PubMed ID: 10996586
    [No Abstract]   [Full Text] [Related]  

  • 60. Intranasal calcitonin and prevention of postmenopausal bone loss.
    Thamsborg G; Storm T; Sykulski R; Brinch E; Andersen NF; Holmegard SN; Soerensen OH
    Lancet; 1988 Feb; 1(8582):413. PubMed ID: 2893209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.